MicroRNA-137 dysregulation predisposes to osteoporotic fracture by impeding ALP activity and expression via suppression of leucine-rich repeat-containing G-protein-coupled receptor 4 expression

Liu,Xiangjun; Xu,Xiaohui

doi:10.3892/ijmm.2018.3690

MicroRNA-137 dysregulation predisposes to osteoporotic fracture by impeding ALP activity and expression via suppression of leucine-rich repeat-containing G-protein-coupled receptor 4 expression

Authors:
- Xiangjun Liu
- Xiaohui Xu
View Affiliations

Affiliations: Department of Orthopedics, The People's Hospital of Huangdao, Qingdao, Shandong 266400, P.R. China
Published online on: May 17, 2018 https://doi.org/10.3892/ijmm.2018.3690
Pages: 1026-1033

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoporosis is defined as a loss of bone mass and deterioration of its architecture resulting in bone weakness, which becomes prone to fracture. The objective of this study was to investigate the molecular mechanism by which miR-137 can reduce the risk of fracture in patients with osteoporosis. An online miRNA database and a luciferase reporter assay system were used to confirm that leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) was the target of miR-137. Real-time PCR and western blot analysis were used to study miR-137 mRNA, the expression of LGR4 mRNA and protein among different groups or cells transfected with a scrambled miRNA control, miR-137 mimic, LGR4 siRNA and miR-137 inhibitor. Expression of miR-137 was upregulated to higher levels in cells isolated from osteoporosis patients with fracture than in those without fracture. The ‘seed sequence’ was found to be located within the 3' untranslated region (3'-UTR) of LGR4 mRNA by searching an online miRNA database. Luciferase reporter assay was performed to confirm that LGR4 is a direct target gene of miR-137 with a potential binding site in the 3'UTR of LGR4. Luciferase activity of cells transfected with wild-type LGR4 3'UTR was much lower than that of the cells transfected with mutant LGR4 3'UTR. The results of real-time PCR and immunohistochemistry experiments demonstrated that the expression levels of LGR4 mRNA and protein were much higher in osteoporosis patients with fracture than osteoporosis patients without fracture. We found that the expression levels of LGR4 mRNA and protein were clearly upregulated following transfection with miR-137 inhibitor, while noticeably downregulated following transfection with miR-137 mimic when compared with the scramble control. Furthermore, the expression of ALP mRNA and ALP activity in bone tissue were much higher in osteoporosis patients with fracture than those without fracture. In conclusion, these data prove that the overexpression of miR-137 was associated with an altered risk of fracture in patients with osteoporosis, and can be used as a biomarker for the prediction of risk of fracture in osteoporosis.

View Figures

View References

1	Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, et al: A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis - From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 45(Suppl 4): S3–S11. 2016. View Article : Google Scholar
2	Melton LJ III, Gabriel SE, Crowson CS, Tosteson AN, Johnell O and Kanis JA: Cost-equivalence of different osteoporotic fractures. Osteoporos Int. 14:383–388. 2003. View Article : Google Scholar : PubMed/NCBI
3	Adachi JD, Ioannidis G, Pickard L, Berger C, Prior JC, Joseph L, Hanley DA, Olszynski WP, Murray TM, Anastassiades T, et al: The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 14:895–904. 2003. View Article : Google Scholar : PubMed/NCBI
4	Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, et al Scientific Advisory Council of Osteoporosis Canada: 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 182:1864–1873. 2010. View Article : Google Scholar : PubMed/NCBI
5	Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N, Ohta H, Shiraki M, Sugimoto T, Suzuki T, et al: Japanese 2011 guidelines for prevention and treatment of osteoporosis - executive summary. Arch Osteoporos. 7:3–20. 2012. View Article : Google Scholar :
6	de Almeida Pereira Coutinho M, Bandeira E, de Almeida JM, Godoi ET, Vasconcelos G and Bandeira F: Low bone mass is associated with increased carotid intima media thickness in men with type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes. 6:1–6. 2013.PubMed/NCBI
7	Ralston SH: Genetics of osteoporosis. Rev Endocr Metab Disord. 2:13–21. 2001. View Article : Google Scholar : PubMed/NCBI
8	Deng HW, Mahaney MC, Williams JT, Li J, Conway T, Davies KM, Li JL, Deng H and Recker RR: Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases. Genet Epidemiol. 22:12–25. 2002. View Article : Google Scholar : PubMed/NCBI
9	Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
10	Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
11	Kozomara A and Griffiths-Jones S: miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42(D1): D68–D73. 2014. View Article : Google Scholar :
12	Pauley KM and Cha S: miRNA-146a in rheumatoid arthritis: a new therapeutic strategy. Immunotherapy. 3:829–831. 2011. View Article : Google Scholar : PubMed/NCBI
13	Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY, et al: miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res. 28:1180–1190. 2013. View Article : Google Scholar
14	Wang Y, Li L, Moore BT, Peng XH, Fang X, Lappe JM, Recker RR and Xiao P: miR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One. 7:e346412012. View Article : Google Scholar : PubMed/NCBI
15	Seeliger C, Karpinski K, Haug AT, Vester H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI
16	Garmilla-Ezquerra P, Sañudo C, Delgado-Calle J, Pérez- Nuñez MI, Sumillera M and Riancho JA: Analysis of the bone microRNome in osteoporotic fractures. Calcif Tissue Int. 96:30–37. 2015. View Article : Google Scholar
17	Pawaputanon Na Mahasarakham C, Ezura Y, Kawasaki M, Smriti A, Moriya S, Yamada T, Izu Y, Nifuji A, Nishimori K, Izumi Y, et al: BMP-2 enhances Lgr4 gene expression in osteoblastic cells. J Cell Physiol. 231:887–895. 2016. View Article : Google Scholar
18	Styrkarsdottir U, Thorleifsson G, Sulem P, Gudbjartsson DF, Sigurdsson A, Jonasdottir A, Jonasdottir A, Oddsson A, Helgason A, Magnusson OT, et al: Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature. 497:517–520. 2013. View Article : Google Scholar : PubMed/NCBI
19	Xiao J, Peng F, Yu C, Wang M, Li X, Li Z, Jiang J and Sun C: microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. Int J Clin Exp Pathol. 7:7442–7450. 2014.
20	Hao S, Luo C, Abukiwan A, Wang G, He J, Huang L, Weber CE, Lv N, Xiao X, Eichmüller SB, et al: miR-137 inhibits proliferation of melanoma cells by targeting PAK2. Exp Dermatol. 24:947–952. 2015. View Article : Google Scholar : PubMed/NCBI
21	Smith AR, Marquez RT, Tsao WC, Pathak S, Roy A, Ping J, Wilkerson B, Lan L, Meng W, Neufeld KL, et al: Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression. Oncotarget. 6:12558–12573. 2015. View Article : Google Scholar : PubMed/NCBI
22	Zhang B, Liu T, Wu T, Wang Z, Rao Z and Gao J: MicroRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. Int J Biol Macromol. 74:111–118. 2015. View Article : Google Scholar
23	Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, et al: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 85:1544–1552. 2003. View Article : Google Scholar : PubMed/NCBI
24	Kozaki K, Imoto I, Mogi S, Omura K and Inazawa J: Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105. 2008. View Article : Google Scholar : PubMed/NCBI
25	Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S and Russo T: miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J. 24:3255–3263. 2010. View Article : Google Scholar : PubMed/NCBI
26	Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, et al: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
27	Langevin SM, Stone RA, Bunker CH, Lyons-Weiler MA, LaFramboise WA, Kelly L, Seethala RR, Grandis JR, Sobol RW and Taioli E: MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer. 117:1454–1462. 2011. View Article : Google Scholar : PubMed/NCBI
28	Zhen G and Cao X: Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci. 35:227–236. 2014. View Article : Google Scholar : PubMed/NCBI
29	Itkin T, Kaufmann KB, Gur-Cohen S, Ludin A and Lapidot T: Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal. Curr Opin Hematol. 20:237–244. 2013.PubMed/NCBI
30	Du B, Luo W, Li R, Tan B, Han H, Lu X, Li D, Qian M, Zhang D, Zhao Y, et al: Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression. J Biol Chem. 288:15131–15141. 2013. View Article : Google Scholar : PubMed/NCBI
31	Mendive F, Laurent P, Van Schoore G, Skarnes W, Pochet R and Vassart G: Defective postnatal development of the male reproductive tract in LGR4 knockout mice. Dev Biol. 290:421–434. 2006. View Article : Google Scholar : PubMed/NCBI
32	Kato S, Matsubara M, Matsuo T, Mohri Y, Kazama I, Hatano R, Umezawa A and Nishimori K: Leucine-rich repeat-containing G protein-coupled receptor-4 (LGR4, Gpr48) is essential for renal development in mice. Nephron Exp Nephrol. 104:e63–e75. 2006. View Article : Google Scholar : PubMed/NCBI
33	Kato S, Mohri Y, Matsuo T, Ogawa E, Umezawa A, Okuyama R and Nishimori K: Eye-open at birth phenotype with reduced keratinocyte motility in LGR4 null mice. FEBS Lett. 581:4685–4690. 2007. View Article : Google Scholar : PubMed/NCBI
34	Song H, Luo J, Luo W, Weng J, Wang Z, Li B, Li D and Liu M: Inactivation of G-protein-coupled receptor 48 (Gpr48/Lgr4) impairs definitive erythropoiesis at midgestation through down-regulation of the ATF4 signaling pathway. J Biol Chem. 283:36687–36697. 2008. View Article : Google Scholar : PubMed/NCBI
35	Mohri Y, Kato S, Umezawa A, Okuyama R and Nishimori K: Impaired hair placode formation with reduced expression of hair follicle-related genes in mice lacking Lgr4. Dev Dyn. 237:2235–2242. 2008. View Article : Google Scholar : PubMed/NCBI
36	Yamashita R, Takegawa Y, Sakumoto M, Nakahara M, Kawazu H, Hoshii T, Araki K, Yokouchi Y and Yamamura K: Defective development of the gall bladder and cystic duct in Lgr4- hypomorphic mice. Dev Dyn. 238:993–1000. 2009. View Article : Google Scholar : PubMed/NCBI
37	Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z, Cho SG, Li C, Yi T, Wu X, et al: Regulation of bone formation and remo-deling by G-protein-coupled receptor 48. Development. 136:2747–2756. 2009. View Article : Google Scholar : PubMed/NCBI